The Motley Fool

5 FTSE 100 shares with yields of 5% or more I’m considering now

Image source: Getty Images.

An investment strategy focused on buying the shares of high-yielding companies can be successful. And many investors target big market capitalisations such as stocks in the FTSE 100 index.

Even big FTSE 100 shares carry some risk

Sometimes big Footsie companies appear to be more stable with mature, well-established businesses. However, even big businesses can go into decline causing their share prices to fall. So, one risk we face following a dividend-led strategy is the possibility that shrinking capital values can erode dividend gains due to falling share prices.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

I reckon one of the most important things to consider when researching dividend investments is the potential sustainability of dividend payments. Therefore, I’d aim to verify that dividend payments have a long history of support from trading. And I’d look for a decent and consistent record of cash flowing into the underlying business. On top of that, I’d also aim to analyse the potential of a business to keep paying dividends in the years ahead.

So, with all those points in mind, should I buy shares in the following five FTSE 100 shares with yields above 5%?

Stock

Recent share price

Forward-looking dividend yield

National Grid

868p

5.7%

Vodafone

126p

6.3%

British American Tobacco

2,765p

8%

GlaxoSmithKline

1,389p

5.8%

Lloyds Banking

32p

5%

National Grid has a unique monopoly position in Britain’s energy infrastructure. Indeed, the firm runs the system for transmitting electricity and gas long distances up, down and across the country to where it’s needed.  And it also operates a regulated energy business in the US.

But one of the risks for investors is that regulatory requirements for capital investment within the business could change in the future. And that could potentially put shareholder dividend payments under pressure. Nevertheless, I’d be tempted to add the stock to my dividend portfolio.

Earnings look set to rebound for Vodafone

Telecoms company Vodafone has a fair bit of debt on its balance sheet, which is something to keep an eye on. Nevertheless, the record of cash flow looks robust and City analysts expect a double-digit percentage rebound in earnings ahead. However, the valuation looks lower than it was three or four years ago. And, on balance, I’m tempted to buy some of the shares to collect the dividend.  

Tobacco volumes are in long-term decline. But British American Tobacco continues to enjoy powerful cash flow and has a record of raising the shareholder dividend incrementally. So, I’m tempted by the fat dividend on offer today.

Although growth in earnings remains elusive for pharmaceutical giant GlaxoSmithKline, the cash flow remains strong and the firm keeps paying shareholder dividends. The payments have remained flat for a number of years. And the share price has dropped a fair bit since the beginning of 2020. But I’m tempted by the stock today.

Lloyds Banking operates a cyclical business. And that’s led to a record of volatile earnings, cash flow and shareholder dividends. The share price has also suffered large swings over the past few years. For those reasons, I’m inclined to avoid the share for my long-term portfolio. Although I reckon the company has the potential to deliver decent shareholder gains over a shorter-term holding period.

One stock for a post-Covid world...

Covid-19 is ripping the investment world in two…

Some companies have seen exploding cash-flows, soaring valuations and record results…

…Others are scrimping and suffering.

Entire industries look to be going extinct.

Such world-changing events may only happen once in a lifetime.

And it seems there’s no middle ground.

Financially, you’ll want to learn how to get positioned on the winning side.

That’s why our expert analysts have put together this special report.

If the pandemic has completely changed our lives forever, then they believe that this stock, hidden inside the tech-heavy NASDAQ, could be set for monstrous gains...

Click here to claim your copy now — and we’ll tell you the name of this US stock… free of charge!

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.